Patent · US Active

Dermatological compositions comprising avermectin nanocapsules

US8309121B2 · kind B2 · utility

5Cited by

2References

21Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Lara Baudonnet · Fonsorbes, FR
Claire Mallard · Mougins, FR

Key dates

Filing date	Apr 10, 2009
Grant date	Nov 13, 2012
Priority date	—
Expiry date	Jan 19, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.